What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

PrECOG Cancer Research Group

Home
United States
Philadelphia, PA
PrECOG Cancer Research Group

Call Directions Website

Innovative cancer research studies developed through industry partnerships and networks.

Supporting ECOG-ACRIN Cancer Research Group's efforts to advance cancer care

10/09/2026

PrE0510 is a randomized phase 2 clinical trial exploring the optimal dose of ivonescimab with carboplatin and etoposide in extensive-stage small cell lung cancer ( ). For more information: bit.ly/PrE0510

10/07/2026

New video: Dr. Shaji Kumar of Mayo Clinic discusses the PrE1005 , which is comparing belantamab mafodotin-VRd vs. daratumumab-VRd for patients with newly diagnosed .

10/06/2026

PrE1005, led by Dr. Shaji Kumar of , is exploring a new treatment option for people with recently diagnosed multiple myeloma. This phase 3 clinical trial compares belantamab mafodotin + VRd versus daratumumab + VRd to determine which approach is more effective. More: https://bit.ly/pre1005-trial

10/02/2026

09/29/2026

Can a BCMA-targeted therapy improve outcomes in newly diagnosed multiple myeloma? PrE1005 is a randomized phase 3 trial comparing belantamab mafodotin + VRd versus daratumumab + VRd. More: https://bit.ly/pre1005-trial

09/25/2026

The PrE0510 clinical trial, led by Dr. Taofeek Owonikoko of , aims to determine the optimal dose of ivonescimab in combo with carboplatin & etoposide for patients with small cell lung cancer. More: https://bit.ly/PrE0510

09/22/2026

Dr. Shaji Kumar of is leading PrE1005, a randomized phase 3 clinical trial treating patients with newly diagnosed multiple myeloma. The study will compare two regimens to see which may lead to better and longer-lasting results. More: https://bit.ly/pre1005-trial

09/18/2026

Dr. Taofeek Owonikoko of is leading PrE0510, a phase 2 clinical trial treating patients with extensive-stage small cell lung cancer ( ) who have not yet had systemic therapy. Learn more: https://bit.ly/PrE0510

Address

1818 Market Street, Suite 3000
Philadelphia, PA
19118

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+12157897001

Website

http://www.precogllc.org/

Alerts

Be the first to know and let us send you an email when PrECOG Cancer Research Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.